1Marks DL,Wu Kang jian,Paul P,et al. Oligomerization and topology of the golgi membrane protein glucosylceramide synthase. J Biol Chem, 1999,274:451-456.
2Cao LP, Duchrow M, Windhovel U, et al. Expression of MDRI mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues. Eur J Cancer, 1998,34:1612-1617.
2Yin MB,Guo B,Voigt W,et al.Novel cellular determination for reversal of multidrug resistance in cells expressing P170-glycoprotein[].Biochimica et Biophysica Acta.1998
3Webb CD,Latham MD,Lock RB,et al.Attenuated topoisomerase Ⅱ content directly correlates with low level of drug resistance in a Chinese hamster ovary cell line[].Cancer Research.1991
4Cole SPCC,Chanda ER,Dicke FP,et al.Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II[].Cancer Research.1991
5Fukuda S,Okuda K,Kinoshita H,et al.Study of hepatic arterial chemoinfusion with continuous CDDP, 5-FU low dose administration for advanced gallbladder cancer[].Gan To Kagaku Ryono.1996
6Vassetaky YS,Alghisi GC,Gasser SM.DNA topoisomerase Ⅱmutations and resistance to anti-tumor drugs[].Bioessays.1995
7Barnes DM,Dubin EA,Fisher CJ,et al.Immunohistochemical detecting of P53 protein in mammary carcinoma: an important new independent indicator of prognosis[].Human Pathology.1993
8Cubertafond P,Gainant A,Cucchiaro G.Surgical treatment of 724 carcinoma of the gallbladder.results of French Surgical Association survey[].Annals of Surgery.1994
